CIRCULATING GRP78/BIP IS INCREASED IN PATIENTS WITH OBESITY AND RELATED METABOLIC DISORDERS AND IS ASSOCIATED WITH ATHEROSCLEROSIS

被引:2
|
作者
Girona, J. [1 ]
Rodriguez-Borjabad, C. [2 ]
Ibarretxe, D. [2 ]
Vallve, J. C. [1 ]
Ferre, R. [2 ]
Heras, M. [1 ]
Rodriguez-Calvo, R. [1 ]
Guaita-Esteruelas, S. [3 ]
Martinez-Micaelo, N. [3 ]
Plana, N. [2 ]
Masana, L. [2 ]
机构
[1] Univ Rovira & Virgili, CIBERDEM, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain
[2] Univ Rovira & Virgili, St Joan Univ Hosp, CIBERDEM, IISPV,Vasc Med & Metab Unit, Reus, Spain
[3] Univ Rovira & Virgili, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain
关键词
D O I
10.1016/j.atherosclerosis.2019.06.402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EAS19-0600
引用
收藏
页码:E136 / E136
页数:1
相关论文
共 50 条
  • [1] The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario
    Girona, Josefa
    Rodriguez-Borjabad, Celia
    Ibarretxe, Daiana
    Vallve, Joan-Carles
    Ferre, Raimon
    Heras, Mercedes
    Rodriguez-Calvo, Ricardo
    Guaita-Esteruelas, Sandra
    Martinez-Micaelo, Neus
    Plana, Nuria
    Masana, Lluis
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [2] Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?
    Giusti, Laura
    Baldini, Chiara
    Ciregia, Federica
    Giannaccini, Gino
    Giacomelli, Camillo
    De Feo, Francesca
    Delle Sedie, Andrea
    Riente, Lucrezia
    Lucacchini, Antonio
    Bazzichi, Laura
    Bombardieri, Stefano
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (03) : 315 - 324
  • [3] Increased expression of the molecular chaperone BiP/GRP78 during the differentiation of a primitive eukaryote
    Lujan, HD
    Mowatt, MR
    Conrad, JT
    Nash, TE
    BIOLOGY OF THE CELL, 1996, 86 (01) : 11 - 18
  • [4] Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological Disorders
    Wang, Miao
    Wey, Shiuan
    Zhang, Yi
    Ye, Risheng
    Lee, Amy S.
    ANTIOXIDANTS & REDOX SIGNALING, 2009, 11 (09) : 2307 - 2316
  • [5] Circulating BiP/Grp78 is a novel prognostic marker for sepsis-mediated immune cell death
    Doerflinger, Marcel
    Reljic, Boris
    Menassa, Joseph
    Nedeva, Christina
    Jose, Irvin
    Faou, Pierre
    Mackiewicz, Liana
    Mansell, Ashley
    Pellegrini, Marc
    Hotchkiss, Richard
    Puthalakath, Hamsa
    FEBS JOURNAL, 2021, 288 (06) : 1809 - 1821
  • [6] Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer
    Kaira, K.
    Toyoda, M.
    Shimizu, A.
    Mori, K.
    Shino, M.
    Sakakura, K.
    Takayasu, Y.
    Takahashi, K.
    Oyama, T.
    Asao, T.
    Chikamatsu, K.
    NEOPLASMA, 2016, 63 (04) : 588 - 594
  • [7] Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma
    Ogawa, Hiroomi
    Kaira, Kyoichi
    Takahashi, Kengo
    Shimizu, Akira
    Altan, Bolag
    Yoshinari, Daisuke
    Asao, Takayuki
    Oyama, Tetsunari
    CANCER BIOMARKERS, 2017, 20 (03) : 273 - 281
  • [8] Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells
    Virrey, Jenilyn J.
    Dong, Dezheng
    Stiles, Caryn
    Patterson, John B.
    Pen, Ligaya
    Ni, Min
    Schoenthal, Axel H.
    Chen, Thomas C.
    Hofman, Florence M.
    Lee, Amy S.
    MOLECULAR CANCER RESEARCH, 2008, 6 (08) : 1268 - 1275
  • [9] High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma
    Yosuke Miura
    Kyoichi Kaira
    Reiko Sakurai
    Hisao Imai
    Yoshio Tomizawa
    Noriaki Sunaga
    Koichi Minato
    Takeshi Hisada
    Tetsunari Oyama
    Masanobu Yamada
    International Journal of Clinical Oncology, 2017, 22 : 872 - 879
  • [10] High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma
    Miura, Yosuke
    Kaira, Kyoichi
    Sakurai, Reiko
    Imai, Hisao
    Tomizawa, Yoshio
    Sunaga, Noriaki
    Minato, Koichi
    Hisada, Takeshi
    Oyama, Tetsunari
    Yamada, Masanobu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (05) : 872 - 879